Latest updates for Hiv Drugs

Fresh curated links around HIV drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • More of key HIV drug to be given
  • More of key HIV drug to be given
  • Lenacapavir Offers Hope To HIV Patients

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

dailynews.co.zw /1 week ago

More of key HIV drug to be given

AUTHORITIES are continuing to escalate their efforts to contain HIV/Aids in the country. In this regard, they say 43 000 citizens will... To access this content, please...

Read source
dailynews.co.zw /1 week ago

More of key HIV drug to be given

AUTHORITIES are continuing to escalate their efforts to contain HIV/Aids in the country. In this regard, they say 43 000 citizens will... To access this content, please...

Read source
tori.ng /1 month ago

Lenacapavir Offers Hope To HIV Patients

Nigeria is transitioning from daily HIV treatment to a biannual Lenacapavir injection, aiming to improve adherence and reduce stigma by transforming a daily regimen into a discreet...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]>

Read source
allafrica.com /2 weeks ago

South Africa: Groundbreaking HIV Drug, Lenacapavir, to Be Launched Next Month

[SAnews.gov.za] The launch of Lenacapavir - a groundbreaking HIV drug - will be held on June 5 in Mpumalanga.

Read source
medcitynews.com /1 month ago

FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral

Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pa...

Read source
medicalxpress.com /2 weeks ago

Children with HIV are living longer but face a rising obesity risk

Advances in HIV treatment have transformed what was once a fatal diagnosis into a manageable chronic condition. Today, children living with HIV are surviving—and increasingly thr...

Read source
borgenproject.org /1 month ago

Lenacapavir’s Introduction in Zimbabwe

Zimbabwe’s Human Immunodeficiency Virus (HIV) epidemic has been among the most severe globally, shaped by decades of social, economic and structural pressures. At the turn of the 2...

Read source
allafrica.com /1 month ago

Nigeria: Lenacapavir - a Welcome Development

[Daily Trust] The fight against HIV/AIDS in Nigeria got a boost with the introduction of twice-yearly injectable Lenacapavir (LEN) in eight states. The rollout, which will begin in...

Read source
poz.com /1 month ago

Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates

With rollout underway in nine countries, early data indicate strong uptake among priority populations.

Read source
channelnewsasia.com /1 week ago

MediSave withdrawal limit for HIV drugs to go up from S$550 to S$850 monthly

The number of new HIV cases has been falling over the years, said the Communicable Diseases Agency, although there was a slight increase in 2025.

Read source
genengnews.com /1 month ago

Long-Term SHIV Suppression Using AAV Gene Therapy

Leronlimab is an antiviral HIV drug that targets and blocks the CCR5 receptor, thus blocking HIV’s ability to invade immune cells. Most macaques that produced sufficient number of...

Read source
nytimes.com /4 days ago

A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?

Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.

Read source
allafrica.com /1 month ago

South Africa: We Are Managing HIV With Selective Lenacapavir Roll-Out, Not Ending It

[Health-e] South Africans are being told that providing a new HIV prevention tool (lenacapavir) to just about 456,000 people is a victory. It is not. In a country that still record...

Read source
thenews-chronicle.com /6 days ago

Anambra Govt launches pre-exposure injectable for HIV Prevention

The Anambra State Ministry of Health over the weekend, flagged off the roll-out of Lenacapavir (LEN PrEP), a long-acting injectable for the prevention of the Human Immunodeficiency...

Read source
bioengineer.org /1 week ago

Diet-Derived Compound Shows Promise in Repairing HIV-Induced Gut Damage, Study Finds

For individuals living with HIV, the advent of antiretroviral therapy (ART) has transformed what was once a fatal diagnosis into a manageable chronic condition. While ART effective...

Read source
allafrica.com /1 month ago

Mozambique: Mozambique Launches Long-Acting Injectable Prep

[AIM] Maputo -- The Mozambican health authorities on Wednesday launched a long-acting injectable PrEP against HIV, which is capable of reducing the risk of infections by more than...

Read source
allafrica.com /2 weeks ago

South Africa: Along Dusty Roads in KZN, a Push for a Groundbreaking HIV Prevention Jab Takes Shape

[spotlight] Along dusty roads in northern KwaZulu-Natal, Spotlight speaks to youth leaders, community mentors and leading scientists who are collaborating to bring a groundbreaking...

Read source
menshealth.com /3 weeks ago

Can We End the HIV Epidemic Once and for All?

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Read source
scienceblog.com /1 month ago

Hidden Proteins in Your Blood Could Stop HIV in Its Tracks

For decades, the problem was the cells themselves. Human CD4+ T cells, the immune sentinels that HIV dismantles so methodically, turned out to be almost impossibly difficult to inf...

Read source
lgbtqnation.com /2 weeks ago

New breakthrough brings researchers closer to a “functional cure” for HIV

Three people were able to suppress the virus for months without their usual treatment regimen.

Read source
gaycitynews.com /4 weeks ago

PrEP4All sues federal government over 2025 HIV prevention research agreement

As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower the cost of Truvada, which is used in pre-exposure prophy...

Read source
latimes.com /1 month ago

Hiltzik: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people

Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.

Read source
allafrica.com /1 month ago

Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF

[allAfrica] Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins S...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Hiv Drugs

allafrica.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

borgenproject.org

Recent coverage from public sources
Public source

dailynews.co.zw

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source